Skip to content

PLx Pharma Winddown Corp.

CIK 0001497504

← back to feed
Revenue (TTM)
$758.1K
−3.3% YoY Q3 Nov 2022
Net Income (TTM)
−$52.78M
−203.2% YoY Q3 Nov 2022
EPS Diluted (TTM)
−$1.71
+9.0% YoY Q3 Nov 2022
Gross Margin
291.0%
Q3 Nov 2022
Operating Margin
-7,048.5%
Q3 Nov 2022
Net Margin
-6,962.4%
Q3 Nov 2022
Free Cash Flow (TTM)
−$28.57M
Q3 Nov 2022
Cash
$25.83M
Q3 Nov 2022
Total Debt
$622.27K
Q3 Nov 2022
Shares Outstanding
29.14M sh
Q3 Nov 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings